Status:
RECRUITING
Efficacy and Safety of Zotarolimus-eluting Stent Overexpansion With OCT
Lead Sponsor:
Yonsei University
Collaborating Sponsors:
Severance Hospital
Medtronic
Conditions:
Coronary Artery Disease
Optical Coherence Tomography
Eligibility:
All Genders
19+ years
Brief Summary
Investigators aimed to evaluate efficacy and safety of expansion capacity of zotarolimus-eluting Stent assessed by optical coherence tomography (OCT) in vivo study.
Detailed Description
Single stent implantation (also called "provisional stenting") is currently the preferred technique for percutaneous coronary interventions on the majority of unprotected left main (LM) or non-LM bifu...
Eligibility Criteria
Inclusion
- Patients, ≥19 years of age, who were diagnosed with IHD requiring stent implantation for lesion with size discrepancy between proximal and distal reference diameter over 1mm, such as tapered long lesion or bifurcation lesion, confirmed by OCT
- The decision to participate voluntarily in this study and the written consent of the patient
Exclusion
- Patients with hypersensitivity or contraindication to antiplatelet treatment
- Female of childbearing potential, who possibly plans to become pregnant any time after enrollment into this study.
- Patients with a life expectancy shorter than 1 year
Key Trial Info
Start Date :
March 23 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2026
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT05340361
Start Date
March 23 2022
End Date
December 31 2026
Last Update
November 25 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Yongin Severance Hospital
Yongin, Gyeonggi-do, South Korea, 16995